Historically, athletic hip injuries have garnered little attention; however, these injuries account for approximately 6% of all sports injuries and their prevalence is increasing. At times, the diagnosis and management of hip injuries can be challenging and elusive for the team physician. Hip injuries are seen in high-level athletes who participate in cutting and pivoting sports that require rapid acceleration and deceleration. Described previously as the “sports hip triad,” these injuries consist of adductor strains, osteitis pubis, athletic pubalgia, or core muscle injury, often with underlying range-of-motion limitations secondary to femoroacetabular impingement. These disorders can happen in isolation but frequently occur in combination. To add to the diagnostic challenge, numerous intra-articular disorders and extra-articular soft-tissue restraints about the hip can serve as pain generators, in addition to referred pain from the lumbar spine, bowel, bladder, and reproductive organs. Athletic hip conditions can be debilitating and often require a timely diagnosis to provide appropriate intervention.
From Columbia Orthopaedics, the Center for Shoulder, Elbow and Sports Medicine, Columbia University Medical Center, New York, NY (Dr. Lynch), the Department of Orthopaedic Surgery, MedSport, University of Michigan Medical School, Ann Arbor, MI (Dr. Bedi), and the Minnesota Orthopedic Sports Medicine Institute at Twin Cities Orthopedics, Edina, MN (Dr. Larson).
Dr. Bedi or an immediate family member serves as a paid consultant to Arthrex; has stock or stock options held in A3 Surgical; and serves as a board member, owner, officer, or committee member of the American Orthopaedic Society for Sports Medicine. Dr. Larson or an immediate family member serves as a paid consultant to Smith & Nephew and A3 Surgical; has stock or stock options held in A3 Surgical; and has received research or institutional support from Smith & Nephew. Neither Dr. Lynch nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article.
Received February 27, 2016
Accepted July 03, 2016